Amgen Inc. (AMGN)
NASDAQ · Healthcare
Amgen Inc. Total Liabilities 2007–2025
Amgen Inc. annual total liabilities history from 2008 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Amgen Inc. total liabilities as of December 31, 2025: 81.93B, a 4.69% decrease year-over-year.
- Amgen Inc. total liabilities for 2025 were 81.93B, a 4.69% decrease from 2024.
- Amgen Inc. total liabilities for 2024 were 85.96B, a 5.46% decrease from 2023.
- Amgen Inc. total liabilities for 2023 were 90.92B, a 47.94% increase from 2022.
- Amgen Inc. total liabilities for 2022 were 61.46B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Amgen Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $81,928 |
| 2024 | $85,962 |
| 2023 | $90,922 |
| 2022 | $61,460 |
| 2021 | $54,465 |
| 2020 | $53,539 |
| 2019 | $50,034 |
| 2018 | $53,916 |
| 2017 | $54,713 |
| 2016 | $47,751 |
| 2015 | $43,366 |
| 2014 | $43,231 |
| 2013 | $44,029 |
| 2012 | $35,238 |
| 2011 | $29,842 |
Amgen Inc. Total Liabilities — FAQ
Amgen Inc. (AMGN) total liabilities over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AMGN's total liabilities history?
The chart and table above show Amgen Inc.'s total liabilities by year and by quarter, including the growth rate.